Skip to main content
Find more clinical trials

GeneMatch

Start: November 2015
End: December 2030
Enrollment: 500000

What Is This Study About?

The GeneMatch program, part of the Alzheimer's Prevention Registry, aims to identify people interested in participating in research studies or clinical trials based in part on their genetic background. GeneMatch will collect genetic information from participants which may be used to match them to studies. Participants are under no obligation to pursue these study opportunities.

Do I Qualify To Participate in This Study?

Minimum Age: 55 Years

Maximum Age: 75 Years

Must have:

  • Willing to provide basic demographic, medical history, and contact information
  • Consent to APOE genotyping without receiving results
  • Resident of the United States

Must NOT have:

  • Unable to comply with GeneMatch requirements
  • Self-reported diagnosis of dementia or any other objective cognitive impairment syndrome
 

Who Is the General Study Contact?

For more information, visit www.endALZnow.org/GeneMatch, or call 1-888-786-7259 or email GeneMatch@endALZnow.org

Study Contact
David Gordon, MS

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Arizona
Banner Alzheimer's Institute
Phoenix, AZ 85006
Recruiting
David Gordon

Who Sponsors This Study?

Lead: Banner Health

Source: ClinicalTrials.gov ID: NCT02564692